- Home
- INO vs VATE Comparison
INO vs VATE Comparison
Compare INO & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- VATE
- Stock Information
- Founded
- INO 1979
- VATE 1994
- Country
- INO United States
- VATE United States
- Employees
- INO N/A
- VATE N/A
- Industry
- INO Medical/Dental Instruments
- VATE Metal Fabrications
- Sector
- INO Health Care
- VATE Industrials
- Exchange
- INO Nasdaq
- VATE Nasdaq
- Market Cap
- INO 69.3M
- VATE 65.1M
- IPO Year
- INO 1998
- VATE 1996
- Fundamental
- Price
- INO $2.38
- VATE $5.05
- Analyst Decision
- INO Buy
- VATE
- Analyst Count
- INO 5
- VATE 0
- Target Price
- INO $8.80
- VATE N/A
- AVG Volume (30 Days)
- INO 2.7M
- VATE 27.4K
- Earning Date
- INO 11-13-2025
- VATE 11-05-2025
- Dividend Yield
- INO N/A
- VATE N/A
- EPS Growth
- INO N/A
- VATE N/A
- EPS
- INO N/A
- VATE N/A
- Revenue
- INO $182,337.00
- VATE $995,000,000.00
- Revenue This Year
- INO N/A
- VATE N/A
- Revenue Next Year
- INO $15,775.73
- VATE N/A
- P/E Ratio
- INO N/A
- VATE N/A
- Revenue Growth
- INO N/A
- VATE N/A
- 52 Week Low
- INO $1.30
- VATE $3.25
- 52 Week High
- INO $7.00
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- INO 55.04
- VATE 47.18
- Support Level
- INO $2.33
- VATE $4.60
- Resistance Level
- INO $2.98
- VATE $5.72
- Average True Range (ATR)
- INO 0.22
- VATE 0.42
- MACD
- INO -0.01
- VATE -0.02
- Stochastic Oscillator
- INO 43.93
- VATE 39.73
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.